We further demonstrated that ectopic CDKN2A expression remarkably inhibited cell proliferation and viability in lung cancer cells, while siRNA‐mediated CDKN2A knockdown greatly promoted cell proliferation and viability. This evidence concerns the gene CDKN2A and lung carcinoma.